Breast cancer, Cancer spread to the brain, Secondary cancers
Results
Phase 1/2
This trial looked at buparlisib (BKM120) with trastuzumab for breast cancer.
It was for people who had :
that had spread to another part of the body (advanced) or into the nearby tissue (locally advanced)
and had got worse while having trastuzumab
The trial was open for people to join between 2011 and 2014. The team published the results in 2018.
Recruitment start: 1 July 2011
Recruitment end: 10 January 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Karla Martins
Experimental Cancer Medicine Centre (ECMC)
National Institute for Health Research Cancer Research Network (NCRN)
Novartis
Last reviewed: 25 Aug 2024
CRUK internal database number: 8614
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
